Titelia

Funds holding ARTELO BIOSCIENCES INC

ISIN US04301G7060 · United States

Fund holders
4
Of which ETFs
0 4 other funds
Value held
20.9K $
Share of capital
0.4 % of 4.6M shares on Aug 11, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 10,12911.3K $0.22 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 6,3768.9K $0.14 %as of May 31, 2026 ↗
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 233326.2 $0.01 %as of May 31, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 181253.4 $0.00 %as of May 31, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q34+316,919+1,000.1 %
2026Q211,538

Institutional managers

8 managers declare this company to the SEC (Form 13F).

ManagerSharesValue
Kathmere Capital Management, LLC13,250100.4K $as of Mar 31, 2026
JANE STREET GROUP, LLC13,07999.1K $as of Mar 31, 2026
CITIGROUP INC3,07623.3K $as of Mar 31, 2026
Tower Research Capital LLC (TRC)2,82621.4K $as of Mar 31, 2026
Clear Street Group Inc.100758 $as of Mar 31, 2026
ROTHSCHILD INVESTMENT LLC215 $as of Mar 31, 2026
CWM, LLC18 $as of Mar 31, 2026
OSAIC HOLDINGS, INC.17 $as of Mar 31, 2026

Declared shareholders of ARTELO BIOSCIENCES INC

There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Mitchell P. Kopin and 2 others4.80 %173,914as of Jun 30, 2026 · SCHEDULE 13G
Armistice Capital, LLC and 1 other0.00 %0as of Jun 30, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding ARTELO BIOSCIENCES INC". https://titelia.com/en/stocks/artelo-biosciences-inc-US04301G7060